Pulse pressure and diabetes treatments

Diabetes, pulse pressure and cardiovascular mortality: the Hoorn Study.

OBJECTIVE Type 2 diabetic patients have an increased arterial stiffness and a very high risk of cardiovascular death. The present study investigated the relationship between pulse pressure, an indicator of vascular stiffness, and risk of cardiovascular mortality among type 2 diabetic and non-diabetic individuals. Second, we determined the relationship between pulse pressure and its main determi...

Blood Pressure and Pulse Pressure Effects on Renal Outcomes in the Veterans Affairs Diabetes Trial (VADT)

OBJECTIVE Blood pressure (BP) control for renal protection is essential for patients with type 2 diabetes. Our objective in this analysis of Veterans Affairs Diabetes Trial (VADT) data was to learn whether on-study systolic BP (SBP), diastolic BP (DBP), and pulse pressure (PP) affected renal outcomes measured as albumin-to-creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR). ...

Pulse pressure and microvessels.

Ageing and ankle pulse pressure.

BACKGROUND Pulse pressure (PP) is a marker of arterial stiffness. Ageing of the arterial system is accompanied by atherosclerosis of coronary arteries and atherosclerosis of popliteal artery. However, severe impairment of the brachial artery is rare. This study investigates whether there is any significant inter-limb (brachial/ankle) PP difference. METHODS Blood pressure was measured in a gro...

Pulse pressure and antihypertensive agents.

Pulse Pressure and Antihypertensive Agents To the Editor: In their subanalysis of the LIFE study,1 the authors conclude that they “show superior protection against stroke in patients treated with losartan when compared with atenolol . . . This difference may be related to specific effects of angiotensin type 1 receptor antagonism . . . beyond blood BP reduction.” The authors do not consider the...